SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-23-004043
Filing Date
2023-06-09
Accepted
2023-06-09 16:15:15
Documents
15
Period of Report
2023-06-09
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT coeptis_8k.htm   iXBRL 8-K 33517
2 PRESS RELEASE coeptis_ex9901.htm EX-99.1 12603
3 GRAPHIC image_001.jpg GRAPHIC 4509
  Complete submission text file 0001683168-23-004043.txt   274095

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE coep-20230609.xsd EX-101.SCH 3200
5 XBRL DEFINITION FILE coep-20230609_def.xml EX-101.DEF 26557
6 XBRL LABEL FILE coep-20230609_lab.xml EX-101.LAB 36481
7 XBRL PRESENTATION FILE coep-20230609_pre.xml EX-101.PRE 25181
9 EXTRACTED XBRL INSTANCE DOCUMENT coeptis_8k_htm.xml XML 5340
Mailing Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090
Business Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090 724-934-6467
Coeptis Therapeutics Holdings, Inc. (Filer) CIK: 0001759186 (see all company filings)

IRS No.: 981465952 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39669 | Film No.: 231005435
SIC: 2836 Biological Products, (No Diagnostic Substances)